Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2019: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
The reduction of Hippocampal cholinergic neurostimulating peptide (HCNP) may induce the inhibition of theta oscillation in CA1, and exhibit a diminished cholinergic projection to CA1 and direct decrease of acethylcholine concentration in hippocampus. While synthetic Aβ oligomers suppressed the hippocampal glutamatergic activity in a concentration-dependent manner, HCNP prevents the suppression of hippocampal glutamatergic neuronal activity induced by synthetic Aβ oligomers. To clarify the cholinergic effect on memory impairement in APP gene-mutated model, we achieved to generate a novel model; APP knock-in mice with HCNP knockout, being Alzheimer's model with lower cholinergic function from medial septal nucleus to hippocamps.
|